Delivery Order SPE2DB20D1051-SPE2DB26FD5WD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors in 0.5 mL units. This firm fixed-price delivery order, valued at $2,867.98, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The award was made through competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mounjaro 10 mg/0.5 mL pen injectors with a ceiling value of $1,285.13. This firm fixed-price delivery order, which is not set-aside designated, represents a competitive procurement under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on September 5, 2025. This competitively awarded, non-set-aside contract has a ceiling value of $3,069.11 and is structured as a firm fixed price delivery order with an ultimate completion date of September 8, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors, with a contract ceiling value of $6,947.95. This competitively awarded, firm fixed-price delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order represents a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,349.62 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injectors on September 19, 2025, with a completion date of September 22, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's substantial...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen injectors with a ceiling value of $4,897.62. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 26, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger indefinite delivery...
- The Defense Logistics Agency (DLA) awarded a $1,360.45 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors on April 24, 2025, with completion scheduled for April 25, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,760.19 to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 ml pen injectors on September 25, 2025, with completion targeted for September 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors with a ceiling value of $58,321.91 under firm fixed pricing. This is a non-set-aside competitively awarded delivery order with an ultimate completion date of September 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical...
- The Defense Logistics Agency (DLA) awarded a $12,595.03 delivery order to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pen injectors, with a completion date of June 3, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the prime contractor. The contract represents a single delivery order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through...
- SPE2DB20D1051Indefinite Delivery Contract
- SPE2DB20D1051-SPE2DB26FD5WDDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injectors at a ceiling value of $1,266.72. This competitively awarded, firm fixed-price delivery order, with an ultimate completion date of October 16, 2025, represents a continuation of pharmaceutical procurement under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The product will be performed and delivered from AmerisourceBergen's Conshohocken, Pennsylvania location, with no set-aside designation applied to this award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills a critical role in the federal medical supply chain. The company's DLA prime contract vehicle enables the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including service to the Defense Health Agency and U.S. Coast Guard. This specific delivery order for the diabetes medication Mounjaro exemplifies the company's ongoing role in supplying specialty pharmaceutical products to federal healthcare systems through competitively awarded, firm fixed-price transactions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 10/15/25 |